Estrogen modulates AT1 receptor gene expression in vitro and in vivo

Circulation

Volumn 97, Issue 22, 1998, Pages 2197-2201

  Nickenig, Georg ^a   Bäumer, Anselm T ^a   Grohè, Christian ^b   Kahlert, Stefan ^b   Strehlow, Kerstin ^a   Rosenkranz, Stephan ^a   Stäblein, Alexander ^a   Beckers, Frank ^a   Smits, Jos F M ^c   Daemen, Mat J A P ^c   Vetter, Hans ^b   Böhm, Michael ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b UNIVERSITY HOSPITAL BONN   (Germany)

^c MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Angiotensin; Atherosclerosis; Genes; Hormones; Hypertension; Muscle, smooth

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ESTRADIOL; ESTROGEN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MESSENGER RNA; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR; VASOCONSTRICTOR AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; ATHEROSCLEROSIS; BLOOD PRESSURE REGULATION; CELL GROWTH; CONTROLLED STUDY; ESTROGEN DEFICIENCY; ESTROGEN THERAPY; FEMALE; FLUID BALANCE; GENE EXPRESSION; HYPERTENSION; LIGAND BINDING; NONHUMAN; OVARIECTOMY; PLASMA RENIN ACTIVITY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RAT; RECEPTOR DENSITY; RECEPTOR DOWN REGULATION; VASCULAR SMOOTH MUSCLE; ANIMAL; CELL CULTURE; CYTOLOGY; DOWN REGULATION; DRUG ANTAGONISM; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PHYSIOLOGY; WISTAR KYOTO RAT;

ANGIOTENSIN II; ANIMALS; AORTA; CELLS, CULTURED; DOWN-REGULATION; ESTRADIOL; ESTROGENS; FEMALE; GENE EXPRESSION REGULATION; MUSCLE, SMOOTH, VASCULAR; OVARIECTOMY; RATS; RATS, INBRED WKY; RECEPTORS, ANGIOTENSIN; RNA, MESSENGER; VASOCONSTRICTOR AGENTS;

EID: 0032499527     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.97.22.2197     Document Type: Article

References (24)

1. Colditz GA, Willett WC, Stampfer MJ, Rosner B, Speizer FE, Hennekens CH. Menopause and the risk of coronary heart disease in women. N Engl J Med. 1987;316:1105-1110.
2. Hong MK, Romm PA, Reagan K, Green CE, Rackley CE. Effects of estrogen replacement therapy on serum lipid values and angiographically defined coronary artery disease in postmenopausal women [see comments). Am J Cordial. 1992;69:176-178.
3. Heckbert SR, Weiss NS, Koepsell TD, Lemaitre RN, Smith ML, Siscovick DS, Lin D, Psaty BM. Duration of estrogen replacement therapy in relation to the risk of incident myocardial infarction in postmenopausal women. Arch Intern Med. 1997;157:1330-1336.
4. Nabulsi AA, Folsom AR, White A, Patsch W, Heiss G, Wu KK, Szklo M. Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women: the Atherosclerosis Risk in Communities Study. N Engl J Med. 1993;328:1069-1075.
5. Cauley JA, La PR, Kuller LH, Bates M, Sandler RB. Menopausal estrogen use, high density lipoprotein cholesterol subfractions and liver function. Atherosclerosis. 1983;49:31-39.
6. Karas RH, Patterson BL, Mendelsohn ME. Human vascular smooth muscle cells contain functional estrogen receptor. Circulation. 1994;89:1943-1950.
7. Grohè C, Kahlen S, Lobbert K, Van EM, Stimpel M, Vetter H, Neyses L. Effects of moexiprilat on oestrogen-stimulated cardiac fibroblast growth, Br J Pharmacol. 1997;121:1350-1354.
8. Grohè C. Cardiac myocytes and fibroblasts contain functional estrogen receptors. FEBS Lett. 1997;416:107-112.
9. Tanaka M, Nakaya S, Watanabe M, Kumai T, Tateishi T, Kobayashi S. Effects of ovariectomy and estrogen replacement on aorta angiotensin-converting enzyme activity in rats. Jpn J Pharmacol. 1997;73:361-363.
10. De Lignieres B, Basdevant A, Thomas G, Thalabard JC, Mercier-Bodard C, Conard J, Guyene IT, Mairon S, Corvol P, Guy-Grand B. Biological effects of estradiol-17 beta in postmenopausal women: oral versus percutaneous administration. J Clin Endocrinol Melab. 1986;62:536-541.
11. Hassager C, Riis BJ, Strom V, Guyene TT, Christiansen C. The long-term effect of oral and percutaneous estradiol on plasma renin substrate and blood pressure. Circulation. 1987;76:753-758.
12. Erkkola R, Lammintausta R, Punnonen R, Rauramo L. The effect of estriol succinate therapy on plasma renin activity and urinary aldosterone in postmenopausal women. Maturitas. 1978;1:9-14.
13. Schunkert H, Danser AH, Hense HW, Derkx FH, Kurzinger S, Riegger GA. Effects of estrogen replacement therapy on the renin-angiotensin system in postmenopausal women. Circulation. 1997;95:39-45.
14. Timmermans PB, Wong PC, Chiu AT, Herblin WF, Benfield P, Carini DJ, Lee RJ, Wexler RR, Saye JA, Smith RD. Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol Rev. 1993;45:205-251.
15. Nickenig G, Murphy TJ. Down-regulation by growth factors of vascular smooth muscle angiotensin receptor gene expression. Mol Pharmacol. 1994;46:653-659.
16. Nickenig G, Murphy TJ. Enhanced angiotensin receptor type 1 mRNA degradation and induction of polyribosomal mRNA binding proteins by angiotensin II in vascular smooth muscle cells. Mol Pharmacol. 1996;50:743-751.
17. Nickenig G, Sachinidis A, Michaelsen F, Böhm M, Seewald S, Vetter H. Upregulation of vascular angiotensin II receptor gene expression by low-density lipoprotein in vascular smooth muscle cells. Circulation. 1997;95:473-478.
18. Nickenig G, Jung O, Strehlow K, Zolk O, Linz W, Scholkens BA, Böhm M. Hypercholesterolemia is associated with enhanced angiotensin AT1 receptor expression. Am J Physiol. 1997;272(Heart Circ Physiol 41): H2701-H2707.
19. Nickenig G, Paul M, Laufs U, Knorr A, Böhm M. Down-regulation of AT1 receptor gene expression in TG(mREN2)27 rats. Br J Pharmacol. 1997;121:134-140.
20. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362:801-809.
21. Griendling KK, Lassegue B, Murphy TJ, Alexander RW. Angiotensin II receptor pharmacology. Adv Pharmacol. 1994;28:269-306.
22. Speir E, Zu X, Cannon RO. Estrogen inhibits free radical generation, viral promotor activity and viral replication induced by cytomegalovirus infection of human smooth muscle cells. Circulation. 1997;96(suppl I):45. Abstract.
23. Kaulhausen H, Venn HJ, Muhlbauer W, Beck KJ, Breuer H. Effect of ethinyl estradiol on renin activity and on the concentrations of renin substrate and aldosterone in plasma of ovariectomized women. Arch Gynecol. 1980;229:29-36.
24. Nickenig G, Strehlow K, Schnabel P, Böhm M. Hypertension and salt sensitivity: the important role of AT1 receptor regulation. Circulation. 1997;96(suppl I):407. Abstract.